Bajaj Healthcare Limited (BHL), a leading specialized chemical and pharmaceutical manufacturer, has announced the re-appointment of Mr. Anil Champalal Jain as its Managing Director. The new term is set to begin on April 1, 2026. A veteran of the pharmaceutical industry, Mr. Jain has been a driving force behind the company’s expansion into Active Pharmaceutical Ingredients (APIs) and finished formulations. This move ensures leadership continuity as the company seeks to scale its manufacturing capabilities and global export footprint over the coming years.
